The Insides Company, the world-first developer of purpose-built chyme reinfusion devices for severe intestinal failure.
Chyme reinfusion therapy (CRT) is a life-saving treatment for patients who have suffered intestinal failure secondary to high-output stomas and fistulas. CRT enables patients to recommence oral feeding, utilizing their own chyme to sustain the body’s nutritional requirements. Chyme reinfusion therapy is demonstrated to improve clinical outcomes, accelerate patient recovery, and allow for early discharge and patient-managed care in their home environments.
The Insides System, a purpose-built medical device for automated chyme reinfusion, enables a patient-managed experience and significant reduction in the labour and handling of chyme compared to traditional methods of manual chyme reinfusion.
To learn more about the The Insides System, visit https://www.theinsides.co/ or contact us for more information.
